DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tartaric acid is an investigational drug.
There have been 9 clinical trials for Tartaric acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2019.
The most common disease conditions in clinical trials are Lymphoma, B-Cell, Venous Thromboembolism, and Lymphoma. The leading clinical trial sponsors are Boehringer Ingelheim, Shiraz University of Medical Sciences, and Mirati Therapeutics Inc.
There are two hundred and seventy-six US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Tartaric acid
|A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers||Population Health Research Institute||Phase 4|
|This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated||Boehringer Ingelheim||Phase 1|
|The Effects of Rhus Coriaria L. on Serum Uric Acid Levels||Shiraz University of Medical Sciences||N/A|
Top disease conditions for Tartaric acid
Top clinical trial sponsors for Tartaric acid
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Tartaric acid||Start Trial||Salts of ranitidine and complexes of bismuth with carboxylic acids, and pharmaceutical compositions thereof||Glaxo Group Limited (GB2)||Start Trial|
|Tartaric acid||Start Trial||Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents||Janssen Pharmaceutica N.V. (Beerse, BE)||Start Trial|
|Tartaric acid||Start Trial||6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof||Pfizer Inc. (New York, NY)||Start Trial|
|Tartaric acid||Start Trial||Organic compounds and their pharmaceutical use||Lilly Industries Limited (Basingstoke, GB2)||Start Trial|
|Tartaric acid||Start Trial||Organic compounds and their use as pharmaceuticals||Lilly S.A. (Alcobendas, ES) Lilly Industries Limited (Basingstoke, GB2)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Tartaric acid||Austria||398200||2008-07-18||Start Trial|
|Tartaric acid||Austria||A172889||2008-07-18||Start Trial|
|Tartaric acid||Australia||3817889||2008-07-18||Start Trial|
|Tartaric acid||Australia||632052||2008-07-18||Start Trial|
|Tartaric acid||Belgium||1003254||2008-07-18||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|